Certified Nutraceuticals (CN) continues to stay on the forefront of research and innovation with new age-related ingredients. Their newest invention, Telos95, is a remarkable achievement that took several years of research and development, clinical research (in vitro) by Life Length´s TAT technology of Spain and the latest human clinical study conducted by Princeton Consumer Research. The DNA test used in the study is “Cawthon qPCR Assay” to test the effectiveness of Telos95.
Telomeres hold remarkable information about the path of our health and may provide the single most important biomarker of aging. They let you track your cellular age based on your telomere length. The length of your telomeres tells you your age in TeloYears, an actionable DNA health test, which could be older or younger than your actual age.
Telomere lengths are reported as the age of your cells and tend to shorten and fray with age. How fast they shorten and eventually become cell senescence (a stage where cells deteriorate- nonfunctional) are all dependent on several factors including: genetics, environment, stress, diet and lifestyle.
Telos95 is formulated with very powerful antioxidant polyphenols and has been clinically shown to decrease your TeloYears age by an average of 8.52 years. It works by decreasing the time it takes to shorten telomere cellular age.
The discovery of Telos95 is the result of more than a decade of research initiated by Ahmad Alkayali, CN CEO and the inventor. The initial research was about SIRT2 Protein and Telomere maintenance in relation to the aging process. After experimenting with many purified natural compounds their research finally succeeded with the perfected composition of Telos95, scientifically validated to decrease TeloYears Cellular Age by 8.52 Years. The human clinical research was conducted by specialist on telomere testing, Princeton Consumer Research. In the yearlong study, eighty-three subjects were screened, eighty-two subjects were enrolled and fifty subjects completed the study. Twenty-five subjects in group A were instructed to take one 95mg. Telos95 capsule once daily and twenty-five subjects in group B took two capsules once daily.